Halofantrine in the treatment of malaria.
D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000378:metabolism; D010616:Phenanthrenes / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D010963:Plasmodium falciparum / Q000187:drug effects
D000962:Antimalarials; D010616:Phenanthrenes; C023768:halofantrine